메뉴 건너뛰기




Volumn 18, Issue 6, 2009, Pages 869-871

Mepolizumab for difficult-to-control asthma with persistent sputum eosinophilia

Author keywords

Asthma; Eosinophilic airways inflammation; IL 5; Mepolizumab

Indexed keywords

CORTICOSTEROID; MEPOLIZUMAB; PREDNISONE;

EID: 67649622321     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543780902922678     Document Type: Review
Times cited : (9)

References (12)
  • 2
    • 0036900913 scopus 로고    scopus 로고
    • Eosinophilic inflammation in sputum of poorly controlled asthmatics
    • Romagnoli M, Vachier I, Tarodo de la Fuente P, et al. Eosinophilic inflammation in sputum of poorly controlled asthmatics. Eur Respir J 2002;20:1370-1377
    • (2002) Eur Respir J , vol.20 , pp. 1370-1377
    • Romagnoli, M.1    Vachier, I.2    Tarodo De La Fuente, P.3
  • 5
    • 33751023463 scopus 로고    scopus 로고
    • Imatinib mesylate for the treatment of hypereosinophilic syndromes
    • Antoniu SA. Imatinib mesylate for the treatment of hypereosinophilic syndromes. Curr Opin Investig Drugs 2006;7:980-984 (Pubitemid 44756123)
    • (2006) Current Opinion in Investigational Drugs , vol.7 , Issue.11 , pp. 980-984
    • Antoniu, S.A.1
  • 7
    • 61849086181 scopus 로고    scopus 로고
    • Mepolizumab and exacerbations of refractory eosinophilic asthma
    • Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-984
    • (2009) N Engl J Med , vol.360 , pp. 973-984
    • Haldar, P.1    Brightling, C.E.2    Hargadon, B.3
  • 8
    • 61849155730 scopus 로고    scopus 로고
    • Mepolizumab for prednisone-dependent asthma with sputum eosinophilia
    • Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-993
    • (2009) N Engl J Med , vol.360 , pp. 985-993
    • Nair, P.1    Pizzichini, M.M.2    Kjarsgaard, M.3
  • 10
    • 6644229440 scopus 로고    scopus 로고
    • Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
    • Leckie MJ, ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148
    • (2000) Lancet , vol.356 , pp. 2144-2148
    • Leckie, M.J.1    Ten Brinke, A.2    Khan, J.3
  • 11
    • 0037718532 scopus 로고    scopus 로고
    • Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions
    • Buttner C, Lun A, Splettstoesser T, et al. Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions. Eur Respir J 2003;21:799-803
    • (2003) Eur Respir J , vol.21 , pp. 799-803
    • Buttner, C.1    Lun, A.2    Splettstoesser, T.3
  • 12
    • 40949146020 scopus 로고    scopus 로고
    • Treatment of patients with the hypereosinophilic syndrome with mepolizumab
    • Rothenberg ME, Klion AD, Roufosse FE, et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008;358:1215-1228
    • (2008) N Engl J Med , vol.358 , pp. 1215-1228
    • Rothenberg, M.E.1    Klion, A.D.2    Roufosse, F.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.